Published in

Nature Research, Nature Communications, 1(12), 2021

DOI: 10.1038/s41467-020-20496-3

Links

Tools

Export citation

Search in Google Scholar

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Journal article published in 2021 by Juliette Coignard, Michael Lush, Tracy A. O’Mara, Jonathan Beesley ORCID, Joe Dennis, Jonathan P. Tyrer, Daniel R. Barnes, Manjeet K. Bolla, Kristan J. Aronson, Antoine de Pauw, Lesley McGuffog, Banu K. Arun, Goska Leslie, Carole Verny-Pierre, Katarzyna Białkowska and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractBreast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.